Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

705
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
705
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

274
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
274
Dementia01:30

Dementia

199
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
199

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quality evaluation of randomized controlled trials of antipsychotic drugs for schizophrenia published in Chinese journals.

Schizophrenia research·2026
Same author

Improving research quality of psychological interventions in evidence-based medicine.

The lancet. Psychiatry·2026
Same author

Synthesis of pyrazolo[5,1-<i>a</i>]isoindoles <i>via</i> silver-mediated cascade cyclization of 1,5-enynes with diazo compounds.

Chemical communications (Cambridge, England)·2026
Same author

A paradigm of the diagnosis and treatment for the whole process of Alzheimer's disease.

Annals of medicine·2026
Same author

Regional homogeneity and interhemispheric connectivity alterations in major depressive disorder.

Asian journal of psychiatry·2026
Same author

Glutathione depletion activates cGAS-STING signaling via oxidative stress in preeclampsia.

Molecular immunology·2026
Same journal

Associations between wearable-device-measured daytime and nighttime light exposures and dementia risk: A prospective cohort study.

General psychiatry·2026
Same journal

Correction to "Resting-state connectivity and tobacco smoking in clinical high-risk for psychosis (NAPLS-3)".

General psychiatry·2026
Same journal

Resilient interpersonal pathways from loneliness to suicidal ideation among Chinese transgender women during global health crises.

General psychiatry·2026
Same journal

Exercise type, dose and mental health outcomes in youth: Which types and doses are sufficient?

General psychiatry·2026
Same journal

Depression meets obesity: Co-occurrence patterns, temporal trends and socioeconomic correlates across 199 countries and territories.

General psychiatry·2026
Same journal

Bilateral repetitive transcranial magnetic stimulation modulates the hemispheric imbalance in major depressive disorder.

General psychiatry·2026
See all related articles

Related Experiment Video

Updated: Sep 28, 2025

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer&#39;s Disease
04:22

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease

Published on: May 20, 2024

1.0K

The China Alzheimer Report 2022.

Rujing Ren1, Jinlei Qi2, Shaohui Lin3

  • 1Department of Neurology and Institute of Neurology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.

General Psychiatry
|April 4, 2022
PubMed
Summary
This summary is machine-generated.

China faces a growing Alzheimer's disease and related dementias (ADRD) crisis amid rapid aging. This report details ADRD trends, economic impact, and public health strategies to support the

Keywords:
cognition disorderseconomics, behavioralpublic health administration

More Related Videos

Author Spotlight: Exploring Acupuncture in Alzheimer's Research from Thread-Embedding Techniques to Clinical Trials
05:54

Author Spotlight: Exploring Acupuncture in Alzheimer's Research from Thread-Embedding Techniques to Clinical Trials

Published on: May 10, 2024

1.6K
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

379

Related Experiment Videos

Last Updated: Sep 28, 2025

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer&#39;s Disease
04:22

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease

Published on: May 20, 2024

1.0K
Author Spotlight: Exploring Acupuncture in Alzheimer's Research from Thread-Embedding Techniques to Clinical Trials
05:54

Author Spotlight: Exploring Acupuncture in Alzheimer's Research from Thread-Embedding Techniques to Clinical Trials

Published on: May 10, 2024

1.6K
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

379

Area of Science:

  • Public Health
  • Epidemiology
  • Gerontology

Background:

  • China's population is rapidly aging, coinciding with a rise in neurodegenerative disorders like Alzheimer's disease and related dementias (ADRD).
  • ADRD is now the fifth leading cause of death in China, imposing significant financial burdens on individuals, families, and society.
  • The 'Healthy China Action' plan (2019-2030) emphasizes a shift towards health maintenance for the growing ADRD population.

Purpose of the Study:

  • To analyze epidemiological trends of ADRD in China.
  • To evaluate the economic burden and public health impact of ADRD.
  • To outline current clinical practices, available resources, and policy recommendations for ADRD prevention and treatment.

Main Methods:

  • Review of epidemiological data on ADRD prevalence, morbidity, and mortality.
  • Economic analysis of ADRD costs, including healthcare utilization and societal impact.
  • Assessment of current diagnostic and treatment strategies and public health resource allocation.

Main Results:

  • ADRD incidence, morbidity, and mortality rates are increasing in China.
  • Significant financial and societal costs associated with ADRD are identified.
  • Gaps in current public health resources and policy frameworks for ADRD management are highlighted.

Conclusions:

  • Urgent public health interventions are needed to address the escalating challenge of ADRD in China.
  • Evidence-based strategies and policy development are crucial for effective ADRD prevention and treatment.
  • Enhanced international collaboration and information exchange can support national efforts in combating ADRD.